191 related articles for article (PubMed ID: 2137857)
1. Antiinflammatory peptides (antiflammins) inhibit synthesis of platelet-activating factor, neutrophil aggregation and chemotaxis, and intradermal inflammatory reactions.
Camussi G; Tetta C; Bussolino F; Baglioni C
J Exp Med; 1990 Mar; 171(3):913-27. PubMed ID: 2137857
[TBL] [Abstract][Full Text] [Related]
2. The anti-inflammatory peptides, antiflammins, regulate the expression of adhesion molecules on human leukocytes and prevent neutrophil adhesion to endothelial cells.
Zouki C; Ouellet S; Filep JG
FASEB J; 2000 Mar; 14(3):572-80. PubMed ID: 10698973
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of the synthesis of platelet-activating factor by anti-inflammatory peptides (antiflammins) without methionine.
Tetta C; Camussi G; Bussolino F; Herrick-Davis K; Baglioni C
J Pharmacol Exp Ther; 1991 May; 257(2):616-20. PubMed ID: 2033508
[TBL] [Abstract][Full Text] [Related]
4. Antiflammins inhibit synthesis of platelet-activating factor and intradermal inflammatory reactions.
Camussi G; Tetta C; Baglioni C
Adv Exp Med Biol; 1990; 279():161-72. PubMed ID: 2096695
[No Abstract] [Full Text] [Related]
5. In vitro and in vivo effects of the anti-inflammatory peptides, antiflammins.
Lloret S; Moreno JJ
Biochem Pharmacol; 1992 Oct; 44(7):1437-41. PubMed ID: 1417964
[TBL] [Abstract][Full Text] [Related]
6. Tumor necrosis factor/cachectin stimulates peritoneal macrophages, polymorphonuclear neutrophils, and vascular endothelial cells to synthesize and release platelet-activating factor.
Camussi G; Bussolino F; Salvidio G; Baglioni C
J Exp Med; 1987 Nov; 166(5):1390-404. PubMed ID: 3119758
[TBL] [Abstract][Full Text] [Related]
7. A specific antagonist of platelet-activating factor suppresses oedema formation in an Arthus reaction but not oedema induced by leukocyte chemoattractants in rabbit skin.
Hellewell PG; Williams TJ
J Immunol; 1986 Jul; 137(1):302-7. PubMed ID: 2940300
[TBL] [Abstract][Full Text] [Related]
8. 'Antiflammins': two nonapeptide fragments of uteroglobin and lipocortin I have no phospholipase A2-inhibitory and anti-inflammatory activity.
Märki F; Pfeilschifter J; Rink H; Wiesenberg I
FEBS Lett; 1990 May; 264(2):171-5. PubMed ID: 2141575
[TBL] [Abstract][Full Text] [Related]
9. Antiflammins. Anti-inflammatory activity and effect on human phospholipase A2.
Cabré F; Moreno JJ; Carabaza A; Ortega E; Mauleón D; Carganico G
Biochem Pharmacol; 1992 Aug; 44(3):519-25. PubMed ID: 1387313
[TBL] [Abstract][Full Text] [Related]
10. Tumor necrosis factor stimulates human neutrophils to release leukotriene B4 and platelet-activating factor. Induction of phospholipase A2 and acetyl-CoA:1-alkyl-sn-glycero-3-phosphocholine O2-acetyltransferase activity and inhibition by antiproteinase.
Camussi G; Tetta C; Bussolino F; Baglioni C
Eur J Biochem; 1989 Jul; 182(3):661-6. PubMed ID: 2546764
[TBL] [Abstract][Full Text] [Related]
11. Nimesulide inhibits platelet-activating factor synthesis in activated human neutrophils.
Verhoeven AJ; Tool AT; Kuijpers TW; Roos D
Drugs; 1993; 46 Suppl 1():52-8. PubMed ID: 7506195
[TBL] [Abstract][Full Text] [Related]
12. Effect of a series of 1-alkyl ether lipids on inhibition of phospholipase A2 activity and PAF responses.
Kohler C; Carroll M; Tarrant E; Torley L; Wissner A
Inflammation; 1993 Jun; 17(3):245-61. PubMed ID: 8330926
[TBL] [Abstract][Full Text] [Related]
13. An anti-inflammatory protein secreted from the rat seminal vesicle epithelium inhibits the synthesis of platelet-activating factor and the release of arachidonic acid and prostacyclin.
Camussi G; Tetta C; Bussolino F; Metafora S; Peluso G; Esposito C; Porta R
Eur J Biochem; 1990 Sep; 192(2):481-5. PubMed ID: 2209604
[TBL] [Abstract][Full Text] [Related]
14. Influence of acyl and plasmalogenic analogs of platelet activating factor on chemotaxis of human leukocytes in vitro and their inflammatory and antiinflammatory activity in vivo.
Kulikov VI; Muzya GI
Biochemistry (Mosc); 2002 Nov; 67(11):1248-52. PubMed ID: 12495421
[TBL] [Abstract][Full Text] [Related]
15. Antiflammin-2, a nonapeptide of lipocortin-1, inhibits leukocyte chemotaxis but not arachidonic acid mobilization.
Moreno JJ
Eur J Pharmacol; 1996 Oct; 314(1-2):129-35. PubMed ID: 8957228
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of eicosanoid and PAF formation by dexamethasone in rat inflammatory polymorphonuclear neutrophils may implicate lipocortin 's'.
Fradin A; Rothhut B; Poincelot-Canton B; Errasfa M; Russo-Marie F
Biochim Biophys Acta; 1988 Nov; 963(2):248-57. PubMed ID: 2848583
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and release of platelet-activating factor is inhibited by plasma alpha 1-proteinase inhibitor or alpha 1-antichymotrypsin and is stimulated by proteinases.
Camussi G; Tetta C; Bussolino F; Baglioni C
J Exp Med; 1988 Oct; 168(4):1293-306. PubMed ID: 3049910
[TBL] [Abstract][Full Text] [Related]
18. Influence of isoproterenol and phosphodiesterase inhibitors on platelet-activating factor biosynthesis in the human neutrophil.
Fonteh AN; Winkler JD; Torphy TJ; Heravi J; Undem BJ; Chilton FH
J Immunol; 1993 Jul; 151(1):339-50. PubMed ID: 8392098
[TBL] [Abstract][Full Text] [Related]
19. Calphostin C, a specific protein kinase C inhibitor, activates human neutrophils: effect on phospholipase A2 and aggregation.
Svetlov S; Nigam S
Biochim Biophys Acta; 1993 May; 1177(1):75-8. PubMed ID: 7683494
[TBL] [Abstract][Full Text] [Related]
20. Effects of nedocromil sodium and WEB 2086 on chemoattractant-stimulated neutrophil migration through cellular and noncellular barriers.
Carolan EJ; Casale TB
Ann Allergy; 1992 Oct; 69(4):323-8. PubMed ID: 1329582
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
